Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 53

1.

Glutathione transport is a unique function of the ATP-binding cassette protein ABCG2.

Brechbuhl HM, Gould N, Kachadourian R, Riekhof WR, Voelker DR, Day BJ.

J Biol Chem. 2010 May 28;285(22):16582-7. doi: 10.1074/jbc.M109.090506. Epub 2010 Mar 23.

2.

Thiol redox systems and protein kinases in hepatic stellate cell regulatory processes.

Brunati AM, Pagano MA, Bindoli A, Rigobello MP.

Free Radic Res. 2010 Apr;44(4):363-78. doi: 10.3109/10715760903555836. Review.

PMID:
20166884
3.

Reactive oxygen species, cellular redox systems, and apoptosis.

Circu ML, Aw TY.

Free Radic Biol Med. 2010 Mar 15;48(6):749-62. doi: 10.1016/j.freeradbiomed.2009.12.022. Epub 2010 Jan 4. Review.

4.

Tumour size and differentiation in predicting recurrence of hepatocellular carcinoma after liver transplantation: external validation of a new prognostic score.

Marelli L, Grasso A, Pleguezuelo M, Martines H, Stigliano R, Dhillon AP, Patch D, Davidson BR, Sharma D, Rolles K, Burroughs AK.

Ann Surg Oncol. 2008 Dec;15(12):3503-11. doi: 10.1245/s10434-008-0128-3. Epub 2008 Sep 6.

PMID:
18777193
5.

Structural determinants of substrate specificity differences between human multidrug resistance protein (MRP) 1 (ABCC1) and MRP3 (ABCC3).

Grant CE, Gao M, DeGorter MK, Cole SP, Deeley RG.

Drug Metab Dispos. 2008 Dec;36(12):2571-81. doi: 10.1124/dmd.108.022491. Epub 2008 Sep 5.

6.

MRP class of human ATP binding cassette (ABC) transporters: historical background and new research directions.

Toyoda Y, Hagiya Y, Adachi T, Hoshijima K, Kuo MT, Ishikawa T.

Xenobiotica. 2008 Jul;38(7-8):833-62. doi: 10.1080/00498250701883514 . Review.

PMID:
18668432
7.

The ABCs of trans(porter) inhibition.

Gaudet R.

Nat Chem Biol. 2008 Aug;4(8):454-5. doi: 10.1038/nchembio0808-454.

PMID:
18641624
8.

Reversal of multidrug resistance by synthetic and natural compounds in drug-resistant MCF-7 cell lines.

Kars MD, I┼čeri OD, Gunduz U, Molnar J.

Chemotherapy. 2008;54(3):194-200. doi: 10.1159/000140462. Epub 2008 Jun 18.

PMID:
18560226
9.

Metallothionein attenuates carmustine-induced oxidative stress and protects against pulmonary fibrosis in rats.

Helal GK, Helal OK.

Arch Toxicol. 2009 Jan;83(1):87-94. doi: 10.1007/s00204-008-0325-7. Epub 2008 Jun 5.

PMID:
18528683
10.

Structural basis of trans-inhibition in a molybdate/tungstate ABC transporter.

Gerber S, Comellas-Bigler M, Goetz BA, Locher KP.

Science. 2008 Jul 11;321(5886):246-50. doi: 10.1126/science.1156213. Epub 2008 May 29.

11.

Cancer chemoprevention and chemotherapy: dietary polyphenols and signalling pathways.

Ramos S.

Mol Nutr Food Res. 2008 May;52(5):507-26. doi: 10.1002/mnfr.200700326. Review.

PMID:
18435439
12.

Single-step doxorubicin-selected cancer cells overexpress the ABCG2 drug transporter through epigenetic changes.

Calcagno AM, Fostel JM, To KK, Salcido CD, Martin SE, Chewning KJ, Wu CP, Varticovski L, Bates SE, Caplen NJ, Ambudkar SV.

Br J Cancer. 2008 May 6;98(9):1515-24. doi: 10.1038/sj.bjc.6604334. Epub 2008 Apr 1.

13.
14.

Reversal of drug resistance of hepatocellular carcinoma cells by adenoviral delivery of anti-ABCC2 antisense constructs.

Folmer Y, Schneider M, Blum HE, Hafkemeyer P.

Cancer Gene Ther. 2007 Nov;14(11):875-84. Epub 2007 Aug 17.

PMID:
17704753
15.
16.

The pharmacology of cancer resistance.

O'Connor R.

Anticancer Res. 2007 May-Jun;27(3A):1267-72. Review.

17.

Harnessing drug resistance: using ABC transporter proteins to target cancer cells.

Leitner HM, Kachadourian R, Day BJ.

Biochem Pharmacol. 2007 Dec 15;74(12):1677-85. Epub 2007 May 21.

18.
19.

Bcl-2 and glutathione depletion sensitizes B16 melanoma to combination therapy and eliminates metastatic disease.

Mena S, Benlloch M, Ortega A, Carretero J, Obrador E, Asensi M, Petschen I, Brown BD, Estrela JM.

Clin Cancer Res. 2007 May 1;13(9):2658-66.

20.

Supplemental Content

Support Center